TrialHuman vaccines & immunotherapeutics2016

Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study.

Stephan Bart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.